Shiaw-Yih Lin
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
- UT MD Anderson Cancer Center · Biomedical Engineering (NIH department code)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #21,535
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6771158Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Internal Medicine
- Biomedical Engineering
NIH Funding · FY2025
Linked Award Amount
$753.5K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#21,535
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Shiaw-Yih Lin as a PI. Multi-PI records show the full award amount for context.
- 5R01CA251206-05R01Contact PIRNase H2 is a novel therapeutic target in triple negative breast cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$384.1Kaward amount
- 5R01CA247862-05R01Contact PIReplication stress response defects predict and enhance immune checkpoint therapy response in triple negative breast cancerUT MD Anderson Cancer Center · Biomedical Engineering (NIH department code)$369.4Kaward amount
Award organization
Organizations that administered FY2025 awards listing Shiaw-Yih Lin as a PI.
FY2025 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT MD Anderson Cancer Center
- 2024$500K Cumulative Funding
- 2024R01 Grant Holder
- 2025$1M Cumulative Funding